FierceBiotech 19. Dez. 2025 Merck turns down option to Evaxion's gonorrhea vaccine, prompting Danish biotech to seek other partners
Endpoints News 18. Dez. 2025 Daiichi and Merck's I-Dxd lung cancer study faces partial hold due to deaths
FierceBiotech 9. Dez. 2025 ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap
Endpoints News 5. Dez. 2025 German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme